Distribution of 18F-5-Fluorouracil in tumor-bearing mice and rats-Reference-Cited by-同舟云学术

Distribution of 18F-5-Fluorouracil in tumor-bearing mice and rats

Published:1978-03 Issue:1 Volume:5 Page:19-28
ISSN:0047-0740
Container-title:International Journal of Nuclear Medicine and Biology
language:en
Short-container-title:International Journal of Nuclear Medicine and Biology

Author:

Shanij J.,Wolf W.,Schlesinger T.,Atkins H.L.,Bradley-Moore P.R.,Casella V.,Fowler J.S.,Greenberg D.,Ido T.,Lambrecht R.M.,MscGregor R.,Mantescu C.,Neirinckx R.,Som P.,Wolf A.P.,Wodinsky I.,Meaney K.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging

Reference45 articles.

1. Adenocarcinomas of stomach, pancreas, liver, and biliary tracts.Survival of 328 patients treated with fluoropyrimidine therapy

2. Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorinated tracers for imaging cancer with positron emission tomography;European Journal of Nuclear Medicine and Molecular Imaging;2004-07-06

2. Radiolabelled Tracers and Anticancer Drugs for Assessment of Therapeutic Efficacy Using PET;Current Pharmaceutical Design;2001-12-01

3. 19F-MRS studies of fluorinated drugs in humans;Advanced Drug Delivery Reviews;2000-03

4. Non-invasive19F-NMRS of 5-fluorouracil in pharmacokinetics and pharmacodynamic studies;NMR in Biomedicine;1998-11

5. Assessment of Tumor Cell Proliferation Using [18F]Fluorodeoxyadenosine and [18F]Fluoroethyluracil;Journal of Pharmaceutical Sciences;1996-03